BEACON THERAPEUTICS HOLDINGS LIMITED
Company number 14303840
- Company Overview for BEACON THERAPEUTICS HOLDINGS LIMITED (14303840)
- Filing history for BEACON THERAPEUTICS HOLDINGS LIMITED (14303840)
- People for BEACON THERAPEUTICS HOLDINGS LIMITED (14303840)
- More for BEACON THERAPEUTICS HOLDINGS LIMITED (14303840)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
02 May 2023 | AP01 | Appointment of Dr Lester Kaplan as a director on 1 May 2023 | |
02 May 2023 | AP01 | Appointment of Mr Khurem Farooq as a director on 1 May 2023 | |
17 Apr 2023 | MA | Memorandum and Articles of Association | |
17 Apr 2023 | RESOLUTIONS |
Resolutions
|
|
17 Apr 2023 | SH08 | Change of share class name or designation | |
05 Apr 2023 | AP01 | Appointment of Dr Ekaterina Smirnyagina as a director on 31 March 2023 | |
04 Apr 2023 | SH01 |
Statement of capital following an allotment of shares on 31 March 2023
|
|
04 Apr 2023 | AP01 | Appointment of Dr Robert Edward Maclaren as a director on 31 March 2023 | |
04 Apr 2023 | AP01 | Appointment of Mr David Andrew Fellows as a director on 31 March 2023 | |
04 Apr 2023 | AP01 | Appointment of Dr Markus Robert John as a director on 31 March 2023 | |
23 Mar 2023 | SH01 |
Statement of capital following an allotment of shares on 14 March 2023
|
|
23 Mar 2023 | SH01 |
Statement of capital following an allotment of shares on 6 March 2023
|
|
22 Mar 2023 | AA01 | Current accounting period extended from 31 March 2023 to 31 December 2023 | |
16 Mar 2023 | SH02 | Sub-division of shares on 6 March 2023 | |
24 Aug 2022 | AA01 | Current accounting period shortened from 31 August 2023 to 31 March 2023 | |
18 Aug 2022 | NEWINC |
Incorporation
Statement of capital on 2022-08-18
|